22.01.2016 • News

Clariant and CB&I Design China Dehydrogenation Plant

© ndoeljindoel - Fotolia.com
© ndoeljindoel - Fotolia.com

Swiss specialty chemicals producer Clariant has won a contract from China’s Hengli Petrochemical (Dalian) Refinery to develop a propane and butane dehydrogenation unit in cooperation with engineering contractor CB&I. The single-train unit, which Clariant said would be the world’s largest when completed, will be built in Dalian in the province of Liaoning. It will be capable of processing 300,000 t/y of propane and 600,000 t/y of isobutane into propylene and isobutylene respectively.

The design will be based on CB&I’s Catofin catalytic dehydrogenation technology using Clariant’s tailor-made catalyst and Heat Generating Material (HGM). A metal-oxide material, HGM is designed to significantly increase the selectivity and yield of Catofin units. It is loaded with the catalyst into the catalyst bed where it oxidates and reduces during operation, producing heat and driving the dehydrogenation reaction. As well as boosting yields, HGM is said to save energy and reduce emissions.

Clariant said Hengli’s plant will be the second co-processing unit to use HGM, following the success of one designed for Shandong Sincier Petrochemical in Dongying, Shandong province. The company added that HGM had also performed very well at Ningbo Haiyue New Material’s propane dehydrogenation plant in Ningbo City, China.

Daniel McCarthy, president of CB&I’s Technology operating group said Catofin technology offered proven reliability and the flexibility to co-process multiple feed compositions at world-scale capacities.

The Catofin process operates at optimum reactor pressure and temperature to maximize propane and isobutane conversion at high yields with correspondingly low investment and operating costs.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.